Aceneuramic acid

醋纽拉酸

Report date: 2024/12/06 16:17:26
NME

Base Information

Drug NameAceneuramic acid
Drug Alias Name唾液酸Sialic acidacidum aceneuramicumSialic acid extended release (Ultragenyx)Sialic acid ER (Ultragenyx) +[19] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSialic acid modulators
TargetsNot applicable
Therapy Area/IndicationsHereditary inclusion body myopathy (HIBM)Distal Myopathies
Global Approved IndicationsDistal Myopathies
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2024/03/26
Country/TerritoryBulgariaCanadaUnited States +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNobelpharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNobelpharma Co Ltd
Inactive CompaniesUltragenyx Pharmaceutical IncTohoku University
Active IndicationsHereditary inclusion body myopathy (HIBM)Distal Myopathies
Inactive IndicationsN/A

Other Information

ATC CodeM09AX05
Related LinksWikipedia